Literature DB >> 11073357

Myotonic dystrophies.

G Meola1.   

Abstract

This review demonstrates genetic and phenotypic heterogeneity in all of the multisystemic myotonic disorders collectively called 'myotonic dystrophies' according to the new nomenclature: myotonic dystrophy type 1, myotonic dystrophy type 2, proximal myotonic myopathy and proximal myotonic dystrophy. Only two loci have so far been assigned (19q 13.3 in myotonic dystrophy type 1, and 3q 21.3 in myotonic dystrophy type 2). Although the diagnosis of these disorders may be suspected clinically, it needs to be confirmed by DNA analysis.

Entities:  

Mesh:

Year:  2000        PMID: 11073357     DOI: 10.1097/00019052-200010000-00003

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  6 in total

Review 1.  Mouse models of triplet repeat diseases.

Authors:  Gillian P Bates; Roman Gonitel
Journal:  Mol Biotechnol       Date:  2006-02       Impact factor: 2.695

2.  Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates.

Authors:  Stefan Winblad; Christer Jensen; Jan-Eric Månsson; Lena Samuelsson; Christopher Lindberg
Journal:  Behav Brain Funct       Date:  2010-05-19       Impact factor: 3.759

Review 3.  Gene therapy in monogenic congenital myopathies.

Authors:  Xuan Guan; Melissa A Goddard; David L Mack; Martin K Childers
Journal:  Methods       Date:  2015-10-14       Impact factor: 3.608

4.  Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1).

Authors:  Stefan Winblad; Christopher Lindberg; Stefan Hansen
Journal:  Behav Brain Funct       Date:  2006-05-15       Impact factor: 3.759

Review 5.  Antisense therapy in neurology.

Authors:  Joshua J A Lee; Toshifumi Yokota
Journal:  J Pers Med       Date:  2013-08-02

Review 6.  Myotonic dystrophy type 1 accompanied with normal pressure hydrocephalus: a case report and literature review.

Authors:  Junyang Wang; Ming Liu; Wenjie Shang; Zhongqin Chen; Guoping Peng
Journal:  BMC Neurol       Date:  2020-02-12       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.